Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)
Condition(s):Carcinoma, Squamous CellLast Updated:August 30, 2010Unknown status
Hide Studies Not Open or Pending
Condition(s):Carcinoma, Squamous CellLast Updated:August 30, 2010Unknown status
Condition(s):Colorectal CancerLast Updated:March 16, 2020Terminated
Condition(s):CancerLast Updated:December 16, 2019Unknown status
Condition(s):Lung Carcinoma; Metastatic Malignant Neoplasm in the Lung; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8Last Updated:February 6, 2024Recruiting
Condition(s):Wild-type RAS Metastatic Colorectal CancerLast Updated:November 8, 2022Completed
Condition(s):EfficacyLast Updated:August 15, 2023Active, not recruiting
Condition(s):Head and Neck Squamous Cell Carcinoma; Recurrent Head and Neck Squamous Cell CarcinomaLast Updated:February 6, 2024Recruiting
Condition(s):Colorectal Cancer; Liver MetastasesLast Updated:May 14, 2019Completed
Condition(s):Anal Squamous Cell CarcinomaLast Updated:May 16, 2018Completed
Condition(s):Colorectal CancerLast Updated:March 24, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.